Internal Medicine: Retrospective Review of 120 Patients Over a 10-Year Period
July 2003
in “
Journal of Cutaneous Medicine and Surgery
”
telogen hair loss serum ferritin cutaneous lupus erythematosus psoriasis NB-UVB phototherapy monoclonal antibodies oral pimecrolimus alefacept infliximab 5% imiquimod cream basal cell carcinoma telogen hair loss ferritin CLE psoriasis UVB phototherapy monoclonal antibodies pimecrolimus Amevive Remicade Aldara BCC
TLDR Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.
In 2003, multiple studies were conducted on various medical conditions and treatments. A retrospective review of 120 patients over a 10-year period found that certain drugs were associated with the development of cutaneous lupus erythematosus (CLE), with most patients improving after discontinuation of the offending drug. Other studies focused on conditions like steroid-induced hypersensitivity, arsenicosis, diabetic foot ulcers, neonatal herpes simplex virus infection, pediatric vasculitis, localized scleroderma, and varicella. Three studies evaluated the efficacy of vaccines against smallpox, genital herpes simplex virus, and human papillomavirus type 16. A study involving 113 patients with psoriasis found that NB-UVB phototherapy applied three times a week cleared psoriasis faster than twice-weekly application. Other studies investigated treatments for psoriasis and dermatitis, including the use of monoclonal antibodies, oral pimecrolimus, alefacept, and infliximab. Two studies established a safe and effective dosing regimen for the treatment of primary nodular basal cell carcinoma using 5% imiquimod cream. A study involving 194 females found no direct relationship between low serum ferritin and chronic diffuse telogen hair loss.